Rhinostics
PrivateLast Round
Series A
Extension
Jun 7, 2022
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Rhinostics operates in Healthcare & Life Sciences and is based in Waltham, Massachusetts. Its latest recorded funding round was a Series A Extension round in June 2022.
Rhinostics is a medical device company that develops and commercializes automated sample collection devices and laboratory workflow solutions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Workflow Automation
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rhinostics Comparables
Compare Rhinostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Copan Diagnostics | 79% | |
| Hamilton Company | 74% | |
| Micronic | 72% |
For institutional investors. Book with your work email.
Rhinostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jun 7, 2022 | ||||
| Series A Extension | Jul 1, 2021 | ||||
| Series A | Mar 11, 2021 |
For institutional investors. Book with your work email.
Rhinostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Avestria Ventures | Series A Extension |
| Wyss Institute for Biologically Inspired Engineering at Harvard University | Seed |
| Covid Apollo Project | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 47% MoM, reaching 1.9K.
- Nov 12, 2025
Monthly visitors increased 38% MoM.
For institutional investors. Book with your work email.
Rhinostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Rhinostics's valuation, stock price, and market status.
Is Rhinostics a public or private company?
Rhinostics is a private company.
What is the current stock price of Rhinostics?
Rhinostics is a private company, so its shares have no public market price. Caplight tracks Rhinostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Rhinostics worth (valuation)?
Valuation information for Rhinostics is not publicly available.
Can I buy Rhinostics stock?
Rhinostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Rhinostics's last funding round?
Rhinostics's most recent funding round was Series A Extension on June 7, 2022.
Who are the main investors in Rhinostics?
Key investors in Rhinostics include Covid Apollo Project.
Will Rhinostics IPO soon?
No public IPO plans have been announced for Rhinostics.
How can I track Rhinostics secondary market activity?
Caplight tracks bids, offers, and trades in Rhinostics's shares on secondary markets.